The influenza virus is a member of the Orthomyxoviridae family of segmented, single-stranded, negatively charged RNA viruses. Three different influenza virus types—A, B, and C—are included in this group. While type B and C viruses only affect humans, type A viruses affect both domesticated and wild birds, horses, swine, other mammals, and humans.In the United States, seasonal epidemics of disease are brought on by human influenza A and B viruses almost every winter. An influenza pandemic can be brought on by the spread of a brand-new, radically different influenza virus. Infections with influenza type C are thought to only cause a mild respiratory illness and not epidemics. Each virus subtype has undergone mutation, resulting in a variety of strains with various levels of pathogenicity; some are pathogenic to one species but not to others, and some are pathogenic to several.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V103848 | (E/Z)-RA-0002034 | 2305572-22-7 | (E/Z)-RA-0002034 is a Chikungunya virus (CHIKV) nsP2 protease inhibitor with IC50 of 58 nM. |
|
V125367 | 3-epi-Dihydroscandenolide | 1137951-08-6 | 3-epi-Dihydroscandenolide is a sesquiterpene lactone that can inhibit influenza A virus. |
|
V127389 | 6-Epi-albassitriol | 178456-58-1 | 6-Epidermotriol can be isolated from Aspergillus spp. FH-A 6357. |
|
V107108 | Actiphenol | 526-02-3 | Actiphenol is an antibiotic that is effective against coxsackievirus B3 and influenza A virus (IC50s = 14.37 and 34.4 µg/mL). |
|
V128325 | ADI-42898 | ADI-42898 is a human IgG1 monoclonal antibody (mAb) that targets envelope polyprotein and M polyprotein. | |
|
V128326 | ADI-65533 | ADI-65533 is a human IgG1 monoclonal antibody (mAb) that targets envelope polyprotein and M polyprotein. | |
|
V128327 | ADI-65534 | ADI-65534 is a human IgG1 monoclonal antibody (mAb) that targets envelope polyprotein and M polyprotein. | |
|
V128425 | AI-181 | AI-181 is a dengue virus type 2 inhibitor. | |
|
V129071 | Anti-Influenza agent 10 | Anti-Influenza agent 10 is an inhibitor of influenza A virus RNA-dependent RNA polymerase (RdRp). | |
|
V129072 | Anti-Influenza agent 11 | 3118478-63-7 | Anti-Influenza Agent 11 is an influenza virus inhibitor that can be used in research on influenza virus infection. |
|
V101734 | Anti-Influenza agent 6 | 2917502-08-8 | Anti-influenza agent 6 (compound 19b) exhibited inhibitory activity against A/WSN/33/H1N1 (EC50 = 0.015 μM) and influenza B viruses Yamagata/16/88 (EC50 = 0.073 μM) and Victotis/2/87 (EC50 = 0.067 μM). |
|
V129073 | Anti-Influenza agent 9 | Anti-Influenza agent 9 is an ion channel blocker for the M2-S31N mutant influenza virus. | |
|
V106010 | Antiviral agent 64 | 1004319-60-1 | Antiviral agent 64 (compound 12) is a diarylheptane compound isolated from Alpinia officinalis. |
|
V106012 | Antiviral agent 65 | 1004319-61-2 | Antiviral agent 65 (Compound 9) is an antiviral agent against influenza A (H1N1) virus (EC50 = 7 μg/mL). |
|
V129195 | Antiviral agent 68 | 87095-75-8 | Antiviral agent 68 is a diarylheptane compound that can be isolated from Alpinia galanga. |
|
V118735 | Antiviral agent 70 | Antiviral agent 70 (compound 12b) is an antiviral agent. | |
|
V109230 | Antiviral agent 78 | 445032-93-9 | Antiviral agent 78 (compound 27) is an antiviral agent. |
|
V129199 | Antiviral agent 81 | Antiviral agent 81 is an orally bioavailable N-acylated remdesivir derivative and RdRp inhibitor with an oral bioavailability of 45.3% (based on exposure to the active metabolite GS-441524), a plasma half-life >8 hours, and reduced CYP3A4 inhibition. | |
|
V94408 | ATV03 | ATV03 is an anti-influenza virus drug with excellent activity against influenza A and B viruses. | |
|
V105057 | ATV2301 | 3049172-60-0 | ATV2301 is an oral anti-influenza drug (EC50 of 1.88 nM for H1N1 and 4.77 nM for H3N2). |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
